Offer - Urjas Oil for just ₹ 1 X
Glucreta M 10/1000 Tablet ER is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Glucreta M 10/1000 Tablet ER safe for pregnant women?
Glucreta M Tablet should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Glucreta M 10/1000 Tablet ER safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Glucreta M Tablet for breastfeeding women are not known.
What is the effect of Glucreta M 10/1000 Tablet ER on the Kidneys?
There may be some adverse effects on kidney after taking Glucreta M Tablet. If you observe any such side effects, stop taking this drug. Consume this medicine again only if your doctor advises you to do so.
What is the effect of Glucreta M 10/1000 Tablet ER on the Liver?
You may experience side effects on your liver after taking Glucreta M Tablet. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Glucreta M 10/1000 Tablet ER on the Heart?
No research work has been carried out till date on effects of Glucreta M Tablet on heart. So it is not known whether taking Glucreta M Tablet will cause side effects on heart or not.
If you are suffering from any of the following diseases, you should not take Glucreta M 10/1000 Tablet ER unless your doctor advises you to do so -
Is this Glucreta M 10/1000 Tablet ER habit forming or addictive?
Forming a habit of Glucreta M 10/1000 Tablet ER has not been reported.
Interaction between Food and Glucreta M 10/1000 Tablet ER
There is no information on the effects of taking Glucreta M 10/1000 Tablet ER with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Glucreta M 10/1000 Tablet ER
Consult your doctor before consuming alcohol while taking Glucreta M 10/1000 Tablet ER as it can have severe side effects.
Yes, Glucreta M Tablet can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Glucreta M Tablet causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Glucreta M Tablet may need to be adjusted.
Glucreta M Tablet is not a known cause of alopecia (hair loss). However, the conditions treated by Glucreta M Tablet type 2 diabetes and PCOS, often list hair loss as a possible symptom.
Yes, Glucreta M Tablet can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with metformin. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia, always keep glucose-rich food with you.
The long-term use can lead to the deficiency of Vitamin B12, which can further lead to megaloblastic anemia. Furthermore, Long-term Metformin use can also lead to kidney and liver problems.
No, you should not take alcohol with Glucreta M Tablet, because it can cause serious side effects which includes hypoglycemia (low blood sugar). The risk of hypoglycemia is higher when you're drinking and taking Glucreta M Tablet than if you're just taking Glucreta M Tablet. Some of the signs of hypoglycemia include dizziness, confusion, and drowsiness.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Farxiga (dapagliflozin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 278